About Us | ScientistIn a world of binary events covering hundreds of drugs there are sure to be some questions.
Frequently Asked Questions
What stocks should I invest in?
BioPharmCatalyst does not issue recommendations regarding the purchase and selling of stocks.
Which companies are listed on BioPharmCatalyst?
The following criteria need to be met in order for a company and its drug pipeline to be listed on BioPharmCatalyst.
1) NASDAQ/NYSE listed. Not OTC.
2) Companies with drugs in clinical (Phase 1-3) development and regulatory catalysts only. MEDICAL DEVICES and DIAGNOSTICS are NOT covered.
In order for a drug event to appear on the FDA Calendar the following additional criteria need to be met:
3) Date or time frame for catalyst must be provided by the company.
4) The above must be provided in a company press release.
If there are companies not listed that satisfy the above criteria, feel free to reach out via the Contact form.
What sources are used to create the FDA Calendar?
SEC Filings and press releases.
Is the FDA Calendar an official resource?
No. The FDA Calendar is run independently of the FDA. There is no affiliation between the FDA and BioPharmCatalyst.
Do you provide data on historical catalysts? Your FDA Calendar page has all sorts of dates for trial results. I'd like to look over the last few years' worth of catalysts.
Yes. Please visit the Historical Catalyst Database.
Why is Company GHJK, currently trading on the OTC exchange not listed on BioPharmCatalyst?
BioPharmCatalyst focuses on companies listed on NASDAQ.
Is the share price shown on your website live?
No. Financial data (e.g. price and volume) are updated once every 20 minutes and that data is already 15 minutes delayed from our feed provider so the data you see will be delayed in total 15-35 minutes.
I noticed you have colors under the different stages (e.g. ARRY Phase 2 has red and orange highlighted under where it says Phase 2. What do these 6 possible color highlights represent?
The six stages represent the different stages of drug development, from Phase 1 (Stage 1) to the final stage when the FDA makes their decision whether to approve the drug or not (Stage 6). This is not an official scale, rather just one used by BioPharmCatalyst.
1) Phase 1, Phase 1b, Phase 1/2
2) Phase 2, Phase 2b
3) Phase 3
4) NDA filing
5) PDUFA
6) Approved/CRL
BioPharmCatalyst Premium - How long does the ($17) per month stay in effect?
Members are locked into the price they signed up to for their current membership.
For example, a member signs up for $17, this price will remain fixed until they cancel their membership. If a member cancels their membership and rejoins the service at a later date they will pay the new rate at the time they rejoin.
Is an API available or is it possible to load data on to an excel file?
An API or other means to load data to Excel is currently is not available.
Users are reminded that scraping on data is not permitted as per the Terms of Use.
"You must not copy, adapt, reproduce, display, frame, mirror, scrape, data-mine, extract, harvest, distribute, transmit, republish, modify or revise the contents of this website in whole or in part in any form or by any means"
Why are some drugs not listed on BioPharmCatalyst?
SMALL CAP - Biotech stocks with key binary events/catalysts - FDA Approval/PDUFA dates, Advisory Committee and Phase 1, 2 & 3 trial data releases dates are noted in the FDA Calendar. If a trial is ongoing but the company has not yet provided an upcoming catalyst date, the drug concerned will ONLY be listed in the Drug Pipeline Database and will not be listed in the FDA Calendar until a catalyst date is provided.
LARGE CAP - generally only Phase 3 catalysts noted in company presentations and/or earnings releases are shown. Earlier stage drugs (Phase 2) are included if the company provides catalyst date updates for the trial in earnings releases/presentations.
Only NASDAQ stocks are covered. Stocks listed on PINK/OTC exchanges are not covered.